Cost-Effectiveness of 6 and 12 Months of Interferon-α Therapy for Chronic Hepatitis C

Abstract

From the standpoint of cost-effectiveness, interferon-alpha therapy for 6 or 12 months may be justified in patients with chronic hepatitis C. The possible exception is patients older than 60 years of age.